JBD prioritizes structured metadata and DOI registration so diabetes bioinformatics research is discoverable across scholarly platforms. Indexing helps findings reach researchers, clinicians, and data science teams who rely on validated evidence.

Our production workflow includes metadata validation and citation checks to improve discoverability and long term accuracy.

JBD maintains core identifiers and metadata services that support reliable citation, cataloging, and discovery across platforms.

• ISSN registration for consistent journal identification
• DOI assignment and metadata registration via Crossref
• Google Scholar discoverability subject to inclusion and crawling guidelines

• Accurate author names, affiliations, and ORCID identifiers
• Funding sources, grant numbers, and conflict disclosures
• Structured abstracts with clear objectives and results
• Domain specific keywords for diabetes bioinformatics
• Complete references with DOIs where available

Authors help improve discoverability by providing complete metadata, accurate references, and clear funding statements. Well structured abstracts and keywords improve visibility for diabetes and bioinformatics audiences.

• Include ORCID identifiers where available
• Use standardized disease and phenotype terminology
• Provide data repository links and accession numbers
• Ensure citations match reference lists

JBD is committed to rigorous, transparent publishing in bioinformatics and diabetes research. We emphasize reproducible computational methods, clear data provenance, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in computational and translational diabetes research.